CD4+ and CD8+ T cells expressed higher percentages of ICOS in the RA cohort, while the naïve marker molecule CD45RA was decreased compared to HCs (Figure 5G; Supplementary Figure 5B). This evidence concerns the gene ICOS and rheumatoid arthritis.